How to buy Guardant Health stock | $99.44

Guardant Health Inc is a diagnostics & research business based in the US. Guardant Health shares (GH) are listed on the NASDAQ and all prices are listed in US Dollars. Guardant Health employs 864 staff and has a trailing 12-month revenue of around 0.00.

Guardant Health stock price (NASDAQ: GH)

Use our graph to track the performance of GH stocks over time.

Guardant Health shares at a glance

• Key figures

Information last updated 2021-10-18.

Latest market close	$99.44
52-week range	$96.66 - $180.83
50-day moving average	$120.84
200-day moving average	$124.89
Wall St. target price	$167.38
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-3.77

Buy Guardant Health shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Guardant Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Guardant Health price performance over time

Historical closes compared with the close of $99.44 from 2021-10-18

1 week (2021-10-12)	-3.99%
1 month (2021-09-17)	-24.70%
3 months (2021-07-19)	-14.89%
6 months (2021-04-19)	-34.97%

1 year (2020-10-19)	-3.21%
2 years (2019-10-18)	52.35%
3 years (2018-10-19)	177.84%
5 years (2016-10-15)	N/A

Guardant Health financials

Revenue TTM	$323.7 million
Gross profit TTM	$194.2 million
Return on assets TTM	-12.65%
Return on equity TTM	-36.74%
Profit margin	-116.99%
Book value	$7.78
Market capitalisation	$10.3 billion

TTM: trailing 12 months

Shorting Guardant Health shares

There are currently 4.6 million Guardant Health shares held short by investors – that's known as Guardant Health's "short interest". This figure is 7.2% up from 4.3 million last month.

There are a few different ways that this level of interest in shorting Guardant Health shares can be evaluated.

Guardant Health's "short interest ratio" (SIR)

Guardant Health's "short interest ratio" (SIR) is the quantity of Guardant Health shares currently shorted divided by the average quantity of Guardant Health shares traded daily (recently around 741462.98076923). Guardant Health's SIR currently stands at 6.24. In other words for every 100,000 Guardant Health shares traded daily on the market, roughly 6240 shares are currently held short.

However Guardant Health's short interest can also be evaluated against the total number of Guardant Health shares, or, against the total number of tradable Guardant Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Guardant Health's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Guardant Health shares in existence, roughly 50 shares are currently held short) or 0.0478% of the tradable shares (for every 100,000 tradable Guardant Health shares, roughly 48 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Guardant Health.

Find out more about how you can short Guardant Health stock.

Guardant Health share dividends

We're not expecting Guardant Health to pay a dividend over the next 12 months.

Guardant Health share price volatility

Over the last 12 months, Guardant Health's shares have ranged in value from as little as $96.66 up to $180.83. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Guardant Health's is 0.526. This would suggest that Guardant Health's shares are less volatile than average (for this exchange).

Guardant Health overview

Guardant Health, Inc. , a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing tests from its LUNAR program for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; LUNAR-2 test for the early detection of cancer in asymptomatic individuals eligible for cancer screening; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for residual disease and recurrence monitoring; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Daiichi Sankyo has collaboration with Guardant Health to develop Guardant360 CDx as a companion diagnostic for Enhertu in advanced metastatic non-small cell lung cancer.

Frequently asked questions

What percentage of Guardant Health is owned by insiders or institutions?
Currently 4.438% of Guardant Health shares are held by insiders and 90.703% by institutions. How many people work for Guardant Health?
Latest data suggests 864 work at Guardant Health. When does the fiscal year end for Guardant Health?
Guardant Health's fiscal year ends in December. Where is Guardant Health based?
Guardant Health's address is: 505 Penobscot Drive, Redwood City, CA, United States, 94063 What is Guardant Health's ISIN number?
Guardant Health's international securities identification number is: US40131M1099 What is Guardant Health's CUSIP number?
Guardant Health's Committee on Uniform Securities Identification Procedures number is: 40131M109